Orlando Health Cancer Institute

Overview

Established in 2020 Orlando Health Cancer Institute’s Bone Marrow Transplant & Cellular Therapy program is part of the state-of-the-art, 10-story Charles Lewis Pavilion on the downtown Orlando campus. The program provides cellular therapy and stem cell transplantation for patients with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failures, and aplastic anemias. We offer autologous as well as allogeneic transplantation using all donor sources being matched siblings, unrelated donors, and alternative sources such as haploidentical and cord blood. The program offers inpatient and ambulatory services. Our institution obtained FACT accreditation February 1, 2023.

This center has been performing allogeneic transplants since 2021 and has been an NMDP transplant center since April 2022.

Attending physicians

Adult - Yasser Khaled, Samer Khaled, Juan Carlos Varela

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants

Adult only

Other programs and services

This institute is a certified center for CAR T cell therapy treating Acute Lymphocytic Leukemia, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Multiple Myeloma.

Discounts with local hotels and short-term lodging.

Our Integrative Medicine Department offers a wide array of therapeutic support and interventions. These services include art classes, yoga, oncology medical massages, music therapy, support groups, crisis line, and patient & family counseling.

Patient survival information for this center

This center's actual 1-year survival results are above the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 34 patients.

The actual 1-year survival of these patients is 79.4%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 49.1% and 78.7%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

120

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 1	PBSC 17	Cord blood 0	Total 18
Unrelated donor	Marrow 0	PBSC 33	Cord blood 1	Total 34
Total allogeneic	Marrow 1	PBSC 50	Cord blood 1	Total 52
Autologous	Marrow Both marrow & PBSC 68	PBSC —	Cord blood —	Total 68
Total combined	Marrow Both marrow & PBSC 119	PBSC —	Cord blood 1	Total 120

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 0	19-44 3	45-64 9	65+ 6	Total 18
Unrelated	0-18 0	19-44 8	45-64 17	65+ 9	Total 34
Autologous	0-18 0	19-44 7	45-64 25	65+ 36	Total 68
Total	0-18 0	19-44 18	45-64 51	65+ 51	Total 120

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Transplant center resources

Transplant center coordinator

Deborah Isayyid

Phone: 321-841-4198

Email: deborah.isayyid@orlandohealth.com

If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

More resources

Choosing a transplant center
Preparing for transplant
Learn about transplant outcomes and treatment decisions (Opens in a new tab)
Support and resources (including non-English materials)
U.S. Transplant Data by Center (Opens in a new tab)
at blood cell.transplant.hrsa.gov

No survivorship program information is available. Contact the center for information about post-transplant care.